期刊
JOURNAL OF MEDICAL GENETICS
卷 53, 期 12, 页码 793-797出版社
BMJ PUBLISHING GROUP
DOI: 10.1136/jmedgenet-2016-103842
关键词
-
资金
- Istituto Pasteur Italia- Fondazione Cenci Bolognetti
- Ministero Universita e Ricerca, Progetti Universitari, Sapienza Universita di Roma
Floating-Harbor syndrome (FHS) is a rare human disease characterised by delayed bone mineralisation and growth deficiency, often associated with mental retardation and skeletal and craniofacial abnormalities. FHS was first described at Boston's Floating Hospital 42 years ago, but the causative gene, called Srcap, was identified only recently. Truncated SRCAP protein variants have been implicated in the mechanism of FHS, but the molecular bases underlying the disease must still be elucidated and investigating the molecular defects leading to the onset of FHS remains a challenge. Here we comprehensively review recent work and provide alterative hypotheses to explain how the Srcap truncating mutations lead to the onset of FHS.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据